Ingevity (NYSE:NGVT – Get Free Report) is expected to be issuing its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to announce earnings of $1.31 per share and revenue of $312.20 million for the quarter. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Parties are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.
Ingevity (NYSE:NGVT – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $258.00 million during the quarter, compared to analyst estimates of $254.73 million. During the same quarter last year, the company earned $1.01 earnings per share. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. On average, analysts expect Ingevity to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Ingevity Price Performance
Ingevity stock opened at $74.82 on Wednesday. Ingevity has a 52 week low of $39.74 and a 52 week high of $79.29. The business has a 50-day simple moving average of $70.86 and a 200 day simple moving average of $70.40. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. The stock has a market cap of $2.60 billion, a price-to-earnings ratio of -21.08 and a beta of 1.16.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on NGVT
Insiders Place Their Bets
In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at $493,264.98. This represents a 6.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.88% of the stock is owned by insiders.
Hedge Funds Weigh In On Ingevity
A number of hedge funds have recently modified their holdings of NGVT. Global Retirement Partners LLC purchased a new stake in shares of Ingevity during the fourth quarter worth about $27,000. Meeder Asset Management Inc. bought a new position in Ingevity during the 4th quarter valued at approximately $33,000. Geneos Wealth Management Inc. raised its position in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after purchasing an additional 387 shares during the last quarter. Headlands Technologies LLC purchased a new stake in Ingevity in the 2nd quarter worth approximately $46,000. Finally, Kestra Advisory Services LLC purchased a new stake in Ingevity in the 4th quarter worth approximately $47,000. Hedge funds and other institutional investors own 91.59% of the company’s stock.
About Ingevity
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Articles
- Five stocks we like better than Ingevity
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
